Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Mortimer

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|August 21, 2003
Antipsychotic treatment in schizophrenia: atypical options and NICE guidanceAnn M Mortimer
Neuropsychiatric Disease and Treatment|June 27, 2009
Update on the management of symptoms in schizophrenia: focus on amisulprideAnn M Mortimer
The International Journal of Neuropsychopharmacology|February 20, 2004
How do we choose between atypical antipsychotics? The advantages of amisulprideAnn M Mortimer
Expert Opinion on Investigational Drugs|April 23, 2004
Novel antipsychotics in schizophreniaAnn M Mortimer
The British Journal of Psychiatry. Supplement|November 21, 2007
Symptom rating scales and outcome in schizophreniaAnn M Mortimer
Expert Review of Neurotherapeutics|December 7, 2013
Current and future treatment modalities in schizophrenia: novel antipsychotic drugs and cognitive therapyPeter J McKenna, Ann M Mortimer
The International Journal of Social Psychiatry|May 3, 2007
Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional studyAnn M Mortimer, Ahmed Omar Ahmed Al-Agib
The International Journal of Neuroscience|June 19, 2004
Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?Philip J Tyson, Kate H Roberts, Ann M Mortimer
Clinical Schizophrenia & Related Psychoses|July 21, 2010
Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real worldAnn M Mortimer, Praveen Singh, Charles J Shepherd, et al.
Cognitive Neuropsychiatry|March 31, 2006
An early marker for semantic memory impairment in patients with schizophreniaMohammed M Al-Uzri, Keith R Laws, Ann M Mortimer
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Psychiatry : the Journal of the Association of European Psychiatrists|August 21, 2003
Antipsychotic treatment in schizophrenia: atypical options and NICE guidanceAnn M Mortimer
Neuropsychiatric Disease and Treatment|June 27, 2009
Update on the management of symptoms in schizophrenia: focus on amisulprideAnn M Mortimer
The International Journal of Neuropsychopharmacology|February 20, 2004
How do we choose between atypical antipsychotics? The advantages of amisulprideAnn M Mortimer
Expert Opinion on Investigational Drugs|April 23, 2004
Novel antipsychotics in schizophreniaAnn M Mortimer
The British Journal of Psychiatry. Supplement|November 21, 2007
Symptom rating scales and outcome in schizophreniaAnn M Mortimer
Expert Review of Neurotherapeutics|December 7, 2013
Current and future treatment modalities in schizophrenia: novel antipsychotic drugs and cognitive therapyPeter J McKenna, Ann M Mortimer
The International Journal of Social Psychiatry|May 3, 2007
Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional studyAnn M Mortimer, Ahmed Omar Ahmed Al-Agib
The International Journal of Neuroscience|June 19, 2004
Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?Philip J Tyson, Kate H Roberts, Ann M Mortimer
Clinical Schizophrenia & Related Psychoses|July 21, 2010
Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real worldAnn M Mortimer, Praveen Singh, Charles J Shepherd, et al.
Cognitive Neuropsychiatry|March 31, 2006
An early marker for semantic memory impairment in patients with schizophreniaMohammed M Al-Uzri, Keith R Laws, Ann M Mortimer
Pageof 2